Apomatix vs Cybersecurity Evaluation Tool (CSET): Side-by-Side Comparison (2026)
Features, pricing, ratings, and pros & cons — compared head-to-head.
Apomatix is a commercial risk assessment tool by Apomatix. Cybersecurity Evaluation Tool (CSET) is a free risk assessment tool. Compare features, ratings, integrations, and community reviews side by side to find the best risk assessment fit for your security stack.
CST VerdictBased on our analysis of NIST CSF 2.0 coverage, core features, integrations, company size fit, here is our conclusion:
Mid-market and SMB risk and compliance teams drowning in spreadsheets will find real value in Apomatix's asset-to-control linkage and automated treatment guidance, which cuts the manual busywork that kills GRC programs. The platform covers NIST CSF 2.0's full risk management chain from GV.RM strategy through ID.RA assessment and ID.AM asset tracking, with built-in ISO 27001 and CIS 20 control testing that actually enforces rigor rather than just logging checkboxes. Skip this if you need deep third-party risk orchestration or if your organization is large enough to justify purpose-built tools for governance, risk, and audit as separate functions; Apomatix consolidates well for lean teams but doesn't scale into enterprise separation-of-duties complexity.
Cybersecurity Evaluation Tool (CSET)
Organizations assessing industrial control systems and critical infrastructure will get the most from Cybersecurity Evaluation Tool (CSET) because it combines standards-based frameworks with hybrid risk scoring rather than forcing a choose-your-own-adventure through NIST controls. The tool is free, runs on Windows without external dependencies, and maps directly to IEC 62443 and NERC CIP alongside NIST CSF, making it unusually useful for facilities teams who need to speak both engineering and compliance language. Skip this if you're managing primarily IT networks or need continuous monitoring; CSET is an assessment snapshot, not a platform, and it won't replace your vulnerability scanner or SIEM.
